CleopatraRX
Tracked across 1 events · 6 articles · First seen Sep 01, 2026 · Last active Sep 01, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Impact: Licenses the UCLA patents and markets the treatment as PearlPAK; positive study results could increase commercial prospects, though FDA approval is still needed.
Sep 01, 2026 · 6 articles
ERGEN INTELLIGENCE
Track CleopatraRX live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard